News
Mutation in DOCK11 gene explains rare disorder in immune system regulation
Researchers from the Institut de Recerca Sant Joan de Déu - SJD Barcelona Children's Hospital participate in an international study, published in the prestigious scientific journal New England Journal of Medicine, which describes for the first time a new disease of the immune system caused by a mutation of the DOCK11 gene.
A study has revealed an association between mental disorders and premature mortality in the Catalan population
A research team from the Parc Sanitari Sant Joan de Déu · Institut de Recerca Sant Joan de Déu analyses the link between experiencing a mental disorder and the risk of premature death in the Catalan population.
New insights into COVID-19 protection in children have revealed the presence of sACE2 in the saliva
The presence of the soluble angiotensin-converting enzyme 2 (sACE2) in saliva could have implications for COVID-19 infection, prevention and control, according to researchers from the Institut de Recerca Sant Joan de Déu and the University of Catalunya. This study has been published in Scientific Reports.
Metformin, key drug in the battle against type 2 Diabetes, reveals its secrets in a new study
Dr. Manuel Vázquez-Carrera, Institut de Recerca Sant Joan de Déu (IRSJD) and professor from the Faculty of Pharmacy and Food Sciences of the University of Barcelona, leads this new study on metformin, one of the most prescribed drugs for treating type 2 diabetes mellitus.
Agenda
TECSAM | Breakfast & Learn: Mental health and women: challenges in first person
Speaker: Mercè Torrentallé, Alicia Mendo Olmos, Carmen Prieto and Raquel Montllor Linares.
Interviews
Manel González-Piñero
Headof Innovation at CREB UPC and XarTEC SALUT
"Our main objectives are to develop a technologies map of the members of XarTEC SALUT and to find the most effective ways to support them."
Read more More Interviews